22-19714624-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_002688.6(SEPTIN5):c.36G>A(p.Ala12Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00928 in 1,505,664 control chromosomes in the GnomAD database, including 93 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0069 ( 8 hom., cov: 31)
Exomes 𝑓: 0.0096 ( 85 hom. )
Consequence
SEPTIN5
NM_002688.6 synonymous
NM_002688.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.09
Genes affected
SEPTIN5 (HGNC:9164): (septin 5) This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 22-19714624-G-A is Benign according to our data. Variant chr22-19714624-G-A is described in ClinVar as [Benign]. Clinvar id is 774360.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.09 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 8 gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEPTIN5 | ENST00000455784.7 | c.36G>A | p.Ala12Ala | synonymous_variant | 1/12 | 1 | NM_002688.6 | ENSP00000391311.2 | ||
SEPTIN5 | ENST00000406395.5 | c.36G>A | p.Ala12Ala | synonymous_variant | 1/12 | 5 | ENSP00000384535.1 | |||
SEPTIN5 | ENST00000406172.6 | n.36G>A | non_coding_transcript_exon_variant | 1/10 | 5 | ENSP00000385356.2 |
Frequencies
GnomAD3 genomes AF: 0.00687 AC: 1031AN: 150016Hom.: 8 Cov.: 31
GnomAD3 genomes
AF:
AC:
1031
AN:
150016
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00582 AC: 607AN: 104332Hom.: 4 AF XY: 0.00586 AC XY: 342AN XY: 58366
GnomAD3 exomes
AF:
AC:
607
AN:
104332
Hom.:
AF XY:
AC XY:
342
AN XY:
58366
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00955 AC: 12948AN: 1355550Hom.: 85 Cov.: 33 AF XY: 0.00925 AC XY: 6191AN XY: 668964
GnomAD4 exome
AF:
AC:
12948
AN:
1355550
Hom.:
Cov.:
33
AF XY:
AC XY:
6191
AN XY:
668964
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00687 AC: 1031AN: 150114Hom.: 8 Cov.: 31 AF XY: 0.00670 AC XY: 491AN XY: 73320
GnomAD4 genome
AF:
AC:
1031
AN:
150114
Hom.:
Cov.:
31
AF XY:
AC XY:
491
AN XY:
73320
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at